Atlas Trials

A Study of Combination or Sequential Treatment With PEGASYS (Peginterferon Alfa-2a) and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B

Clinical trial NCT00940485 · COMPLETED

Trial details

NCT number
NCT00940485
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis B, Chronic
Start date
2009-04-01
Primary completion
2011-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.